JP2009504576A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009504576A5 JP2009504576A5 JP2008525352A JP2008525352A JP2009504576A5 JP 2009504576 A5 JP2009504576 A5 JP 2009504576A5 JP 2008525352 A JP2008525352 A JP 2008525352A JP 2008525352 A JP2008525352 A JP 2008525352A JP 2009504576 A5 JP2009504576 A5 JP 2009504576A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- glutamine
- source
- use according
- glutamine source
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 claims 16
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 claims 12
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 claims 10
- 108010016626 Dipeptides Proteins 0.000 claims 4
- 229930182816 L-glutamine Natural products 0.000 claims 4
- 108090000765 processed proteins & peptides Proteins 0.000 claims 4
- 206010060932 Postoperative adhesion Diseases 0.000 claims 3
- 230000015572 biosynthetic process Effects 0.000 claims 3
- 238000007912 intraperitoneal administration Methods 0.000 claims 3
- HJCMDXDYPOUFDY-WHFBIAKZSA-N Ala-Gln Chemical group C[C@H](N)C(=O)N[C@H](C(O)=O)CCC(N)=O HJCMDXDYPOUFDY-WHFBIAKZSA-N 0.000 claims 2
- 125000003338 L-glutaminyl group Chemical group O=C([*])[C@](N([H])[H])([H])C([H])([H])C([H])([H])C(=O)N([H])[H] 0.000 claims 2
- 108010044940 alanylglutamine Proteins 0.000 claims 2
- 229960002648 alanylglutamine Drugs 0.000 claims 2
- 238000001356 surgical procedure Methods 0.000 claims 2
- 229940079593 drug Drugs 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 238000009472 formulation Methods 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 210000003200 peritoneal cavity Anatomy 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US70717305P | 2005-08-11 | 2005-08-11 | |
| US60/707,173 | 2005-08-11 | ||
| PCT/CA2006/001319 WO2007016791A1 (en) | 2005-08-11 | 2006-08-11 | Reducing post-operative adhesion formation with intraperitoneal glutamine |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2009504576A JP2009504576A (ja) | 2009-02-05 |
| JP2009504576A5 true JP2009504576A5 (enExample) | 2009-09-24 |
| JP5194207B2 JP5194207B2 (ja) | 2013-05-08 |
Family
ID=37727066
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008525352A Active JP5194207B2 (ja) | 2005-08-11 | 2006-08-11 | 腹腔内グルタミンによる術後癒着形成の減少 |
Country Status (14)
| Country | Link |
|---|---|
| US (5) | US20100260819A1 (enExample) |
| EP (1) | EP1940439B1 (enExample) |
| JP (1) | JP5194207B2 (enExample) |
| AT (1) | ATE485829T1 (enExample) |
| AU (1) | AU2006279218B2 (enExample) |
| CA (1) | CA2618600C (enExample) |
| CY (1) | CY1112051T1 (enExample) |
| DE (1) | DE602006017864D1 (enExample) |
| DK (1) | DK1940439T3 (enExample) |
| ES (1) | ES2355159T3 (enExample) |
| PL (1) | PL1940439T3 (enExample) |
| PT (1) | PT1940439E (enExample) |
| SI (1) | SI1940439T1 (enExample) |
| WO (1) | WO2007016791A1 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE602006017864D1 (de) | 2005-08-11 | 2010-12-09 | Univ Saskatchewan | It intraperitonealem glutamin |
| CA2578647A1 (en) * | 2007-02-15 | 2008-08-15 | University Of Saskatchewan | Reducing post-operative adhesion formation with intraperitoneal glutamine |
| DK2129370T3 (da) | 2007-03-02 | 2013-02-11 | Zytoprotec Gmbh | Kulhydratbaseret peritonealdialysevæske indeholdende glutaminrest |
| EP2113262B1 (en) * | 2008-04-29 | 2013-11-06 | Proxy Biomedical Limited | A Tissue Repair Implant |
| CN103002903B (zh) * | 2010-06-28 | 2015-04-22 | Ade治疗公司 | 瘢痕疙瘩治疗法 |
| WO2014027545A1 (ja) * | 2012-08-16 | 2014-02-20 | ニプロ株式会社 | 癒着防止材 |
| EP3448421B1 (en) * | 2016-04-29 | 2021-11-03 | The Board of Trustees of the Leland Stanford Junior University | Methods and compositions for the prevention and treatment of surgical adhesions |
| CN109789249B (zh) | 2016-06-15 | 2022-01-25 | 土耳其科学技术研究理事会 | 多功能疝气贴片 |
| US10500318B1 (en) * | 2018-07-03 | 2019-12-10 | Temple Therapeutics BV | Dosing regimens for treating hypoxia-associated tissue damage |
| AU2022271004A1 (en) | 2021-05-07 | 2023-11-16 | Temple Therapeutics BV | Methods of treating fibrosis and hypoxia-associated damage to peripheral nerves |
| WO2025163204A1 (en) | 2024-02-01 | 2025-08-07 | Temple Therapeutics BV | Glutamine source for use in methods and compositions for reducing or preventing synovial joint adhesions or fibrosis |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2026881A1 (en) * | 1989-02-08 | 1990-08-09 | Masao Tanihara | Peptide and adsorbent thereof immobilized on carrier |
| US5248697A (en) | 1990-09-20 | 1993-09-28 | Brigham And Women's Hospital | Enhancement of glutathione levels with glutamine |
| CA2114290C (en) * | 1993-01-27 | 2006-01-10 | Nagabushanam Totakura | Post-surgical anti-adhesion device |
| US5425740A (en) * | 1994-05-17 | 1995-06-20 | Hutchinson, Jr.; William B. | Endoscopic hernia repair clip and method |
| US6965014B1 (en) * | 1996-01-16 | 2005-11-15 | Baxter International Inc. | Fibrin material and method for producing and using the same |
| US6280745B1 (en) * | 1997-12-23 | 2001-08-28 | Alliance Pharmaceutical Corp. | Methods and compositions for the delivery of pharmaceutical agents and/or the prevention of adhesions |
| US5693671A (en) * | 1996-05-01 | 1997-12-02 | Harbor-Ucla Research And Education Institute | L-glutamine therapy for sickle cell diseases and thalassemia |
| GB9609993D0 (en) | 1996-05-14 | 1996-07-17 | Norbrook Lab Ltd | Oral rehydration product |
| US6797729B1 (en) * | 1996-06-28 | 2004-09-28 | Baxter International Inc. | Therapeutic glutamine and N-actyl-cysteine composition |
| US6063061A (en) * | 1996-08-27 | 2000-05-16 | Fusion Medical Technologies, Inc. | Fragmented polymeric compositions and methods for their use |
| US6495579B1 (en) * | 1996-12-02 | 2002-12-17 | Angiotech Pharmaceuticals, Inc. | Method for treating multiple sclerosis |
| AU8918898A (en) * | 1997-08-25 | 1999-03-16 | Harold Brem | Prevention of adhesions and excessive scar formation using angiogenesis inhibi tors |
| AU4572899A (en) * | 1998-06-16 | 2000-01-05 | Biogen, Inc. | Variant type ii tgf-beta receptor fusion proteins and methods |
| WO2000006120A1 (en) | 1998-07-31 | 2000-02-10 | Korea Institute Of Science And Technology | Lipid emulsion and solid lipid nanoparticle as a gene or drug carrier |
| US6613070B2 (en) * | 1998-08-04 | 2003-09-02 | Baxter International Inc. | System and method for sealing vascular penetrations with hemostatic gels |
| US20030007951A1 (en) | 2000-08-23 | 2003-01-09 | Richard Franklin | Treatment of trauma |
| CA2501540A1 (en) * | 2002-10-08 | 2004-04-22 | Abbott Laboratories | Methods and compositions for providing glutamine |
| WO2005030243A1 (en) | 2003-09-26 | 2005-04-07 | Bristol Myers Squibb Company | Arginyl-glutamine dipeptide for treatment of pathological vascular proliferation |
| DE602006017864D1 (de) | 2005-08-11 | 2010-12-09 | Univ Saskatchewan | It intraperitonealem glutamin |
-
2006
- 2006-08-11 DE DE200660017864 patent/DE602006017864D1/de active Active
- 2006-08-11 AU AU2006279218A patent/AU2006279218B2/en active Active
- 2006-08-11 DK DK06775098T patent/DK1940439T3/da active
- 2006-08-11 JP JP2008525352A patent/JP5194207B2/ja active Active
- 2006-08-11 PL PL06775098T patent/PL1940439T3/pl unknown
- 2006-08-11 ES ES06775098T patent/ES2355159T3/es active Active
- 2006-08-11 PT PT06775098T patent/PT1940439E/pt unknown
- 2006-08-11 US US12/063,423 patent/US20100260819A1/en not_active Abandoned
- 2006-08-11 SI SI200630887T patent/SI1940439T1/sl unknown
- 2006-08-11 EP EP20060775098 patent/EP1940439B1/en active Active
- 2006-08-11 AT AT06775098T patent/ATE485829T1/de active
- 2006-08-11 WO PCT/CA2006/001319 patent/WO2007016791A1/en not_active Ceased
- 2006-08-11 CA CA2618600A patent/CA2618600C/en active Active
-
2011
- 2011-01-04 CY CY20111100013T patent/CY1112051T1/el unknown
-
2013
- 2013-02-27 US US13/779,362 patent/US9011883B2/en active Active
-
2015
- 2015-03-17 US US14/660,382 patent/US20150250928A1/en not_active Abandoned
-
2017
- 2017-04-05 US US15/480,148 patent/US20170203013A1/en not_active Abandoned
-
2018
- 2018-11-05 US US16/180,637 patent/US10799622B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7627214B2 (ja) | 発泡体組成物、発泡体マトリックスおよび方法 | |
| US20070286892A1 (en) | Compositions and methods for preventing or reducing postoperative ileus and gastric stasis in mammals | |
| JP2010520186A5 (enExample) | ||
| CN102006893A (zh) | 粘膜组织敷料及其使用方法 | |
| JP2013100347A5 (enExample) | ||
| JP2009269923A5 (enExample) | ||
| JP2005527535A5 (enExample) | ||
| IL203747A (en) | Use of a steroid sex precursor in the manufacture of a 13mg dose or less for daily dosing through the vagina to treat vaginal diseases and a vaginal pharmacological preparation containing it | |
| PL2062602T3 (pl) | Nowy, nietoksyczny i biodegradowalny klej biologiczny przeznaczony do stosowania w chirurgii jamy brzusznej | |
| WO2005043971A3 (en) | Methods of using and compositions comprising selective cytokine inhibitory drugs for treatment, modification and management of pain | |
| NO20061859L (no) | OROS Push Stick for kontrollert tilforsel av aktive midler | |
| JP2019534288A5 (enExample) | ||
| WO2005013936A3 (en) | Manufacture of long term drug delivery devices with polyurethane based polymers | |
| EA201100313A1 (ru) | Способ доставки фармацевтической композиции пациенту, нуждающемуся в этом | |
| JP2005524648A5 (enExample) | ||
| NZ605469A (en) | Nalbuphine-based formulations and uses thereof | |
| NZ612063A (en) | Dental anesthetic comprising tetracaine and a vasoconstrictor for intranasal administration | |
| EA200800663A1 (ru) | Способ и средство профилактики и лечения нарушенного дыхания во время сна | |
| WO2004037207A3 (en) | Methods of using and compositions comprising selective cytokine inhibitory drugs for treatment, modification and management of pain | |
| JP2012508256A5 (enExample) | ||
| NZ583803A (en) | Agents with angiogenic and wound healing activity | |
| IL194500A (en) | A peptide substance capable of increasing capillary resistance and pharmacological preparation containing the above | |
| MXPA05008461A (es) | Equipo para aplicar revestimiento de farmaco a un dispositivo medico en un cuarto del cirujano. | |
| MX2009005503A (es) | Uso de l-carnitina para la preparacion de un medicamento en forma de gotas oculares para el tratamiento de enfermedades de la cornea. | |
| JP2005511708A5 (enExample) |